Studies how signaling programs govern hepatic and intestinal physiology and cancer. Integrates mouse models, 3D cultures, and multi‑omics (genomics, ATAC‑seq, immunohistochemistry) to resolve metabolic zonation, define biomarkers, and reveal therapeutic vulnerabilities.